Assenagon Asset Management S.A.
Position in RCKT — Rocket Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in RCKT
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$290,067
-$64,446 QoQ
Shares Held
84,815
-14.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 11 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. RCKT ranks #63 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in RCKT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $290,067 | 84,815 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $354,513 | 99,026 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $114,127 | 32,515 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $116,760 | 35,816 | Shares | Sole | 2025-10-07 | |
| 2024-06-30 | $645,598 | 29,986 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,174,758 | 80,726 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $21,057,671 | 702,625 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $17,972,598 | 877,140 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $8,495,835 | 427,571 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $7,410,232 | 432,588 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,674,151 | 1,005,322 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $22,103,546 | 1,384,934 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $23,306,165 | 1,693,762 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $20,944,097 | 1,320,561 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $11,721,400 | 536,940 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $877,331 | 29,352 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,581,640 | 35,711 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,591,640 | 35,872 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,429,412 | 44,300 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $7,880,504 | 344,729 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $10,305,220 | 492,366 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||